BG
VERV

Bellevue Group’s Verve Therapeutics VERV Stock Holding History

Bellevue Group’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-29,200
Closed -$388K – 176
2024
Q1 		$388K Sell
29,200
-9,800
-25% -$130K 0.01% 139
2023
Q4 		$544K Buy
+39,000
New +$544K 0.01% 133